Type 1 diabetes mellitus versus type 2 diabetes mellitus

Common Questions and Answers about Type 1 diabetes mellitus versus type 2 diabetes mellitus

diabetes

Avatar m tn [6–9] Some recent data suggest that patients with chronic liver disease who also have type 2 diabetes or other components of metabolic syndrome may be at risk for more advanced fibrosis. This is especially true for NAFLD[10] and possibly HCV.
931217 tn?1283484935 Much less common risks of pregnancy, such as pregnancy toxemia, diabetes mellitus, uterine torsion, uterine rupture, and pregnancy-associated pyelonephritis (kidney infection) can all be prevented by neutering.[13] Mammary Tumors - Mammary tumors are very common in intact female dogs. Incidence is reported in a number of different ways, which makes comparison between studies difficult.
596539 tn?1219982139 Hepatitis C virus (HCV) causes liver diseases and extrahepatic manifestations, and also contributes to insulin resistance and type 2 diabetes mellitus (DM). The aims of the present study were to examine the incidence of extrahepatic manifestations including lichen planus in HCV-infected patients and to evaluate the relationship between lichen planus and insulin resistance. METHODS: Of 9396 patients with liver diseases presenting to the study hospital, 87 patients (mean age 60.0 +/- 11.
Avatar m tn Green Tea Polyphenols Improve Liver Injury of Nonalcoholic Steatohepatitis (NASH) Model Mice Expressing Nuclear Sterol Regulatory Element-Binding Protein 1C (nSREBP-1c) in Adipose Tissue T. Ueno1, 2; T. Nakamura2, 1; R. Sakata2, 1; O. Hashimoto2, 1; K. Inoue2, 1; H. Koga2, 1; T. Torimura2, 1; M. Shinkawa1; H. Nakayama3; S. Otabe3; N. Hirota3; K. Yamada3; M. Sata2, 1 1.
Avatar f tn Yes GS-9190 is a PI that Gilead has in phase 2 clinical trials. I have heard of someone in Florida who has been approved to join the study. He has advanced liver disease so time is of the essence for him. Gilead is a SF Bay Area bio company who does R&D and manufactures Hepatitis drugs, HIV treatment and they are working on anti-fibrosis drugs also. Link to clinical trial: http://www.clinicaltrials.gov/ct2/show/NCT00743795?
233616 tn?1312790796 Our data suggest that the potentially deleterious effects of metformin to AD patients may be avoided by using it in combination with insulin; the combination may result in a beneficial effect in treating both type 2 [diabetes mellitus] and in mitigating AD progression," the researchers write. AD expert Michal S.
Avatar n tn My liver specialist now tells me that the metabolic syndrome -- which includes type 2 diabetes -- can sometimes be worsened by interferons. There was also a fairly recent thread over at the "Janis and Friends" web site that anecdotally showed the same thing -- higher cholesterol levels post treatment. A couple of other related studies: http://clinical.diabetesjournals.org/cgi/content/full/22/1/43 "...Stimulation of immune responses may have deleterious consequences.
Avatar m tn In a cross-sectional survey including 9841 persons, Mehta et al found that HCV-positive persons who were older than 40 years had an increased risk for type 2 diabetes mellitus higher than 3 times compared with persons without HCV-infection Insulin resistance is the main pathogenic factor in the development of steatosis in chronic hepatitis C, both viral insulin resistance and metabolic insulin resistance could be implied in the development of steatosis.
Avatar m tn After given for 24-48 weeks, this treatment resulted in a sustained virologic response (a marker for cure), defined as undetectable HCV RNA in the patient's blood 24 weeks after the end of treatment in 50%–80% of patients (with higher SVR among persons with HCV genotypes 2 or 3 infections versus infections with HCV genotype 1, the most common genotype found in the United States).
Avatar f tn Insulin resistance is the major feature of the metabolic syndrome and depends on insulin secretion and insulin sensitivity. In chronic hepatitis C, insulin resistance and type 2 diabetes mellitus are more often seen than in healthy controls or chronic hepatitis B patients. Hepatitis C virus (HCV) infection promotes insulin resistance, mainly by increased TNF production together with enhancement of suppressor of cytokine (SOC-3); both events block PI3K and Akt phosphorylation.
26471 tn?1211940121 Sutapa Banerjee, Kousuke Saito, Malika Ait-Goughoulte, Keith Meyer, Ratna B Ray, Ranjit Ray Chronic hepatitis C virus (HCV) infection has a significantly increased prevalence of type 2 diabetes mellitus (T2DM). Insulin resistance is a critical component of T2DM pathogenesis. Several mechanisms are likely to be involved in the pathogenesis of HCV related insulin resistance.
148588 tn?1465782409 The guideline is intended for physicians and allied health professionals and provides recommendations that suggest preferred approaches to the diagnosis, therapeutic and preventive aspects of care. While obesity is a risk factor for NAFLD, there is a very high prevalence in individuals with type 2 diabetes mellitus and progression to advanced fibrosis and mortality increases in older patients. The recommendations address NAFLD in children and adults. All quotes are from this new guideline.
Avatar m tn Older patients and patients with poorly controlled diabetes mellitus have a greater risk of developing infections during HCV treatment. ------------------------------------------------------------------- In this study 319 patients: http://www.ncbi.nlm.nih.gov/pubmed/18458815 During the treatment with pegylated interferons and ribavirin, we did not find a correlation between neutropenia and infections.
419309 tn?1326506891 1 In a report in this issue of Gastroenterology, Lok et al2 provide evidence that the incidence of hepatocellular carcinoma is also not different in those who were on maintenance therapy versus untreated controls. These results are in contradistinction to an earlier report on 2-year maintenance therapy in nonresponders.3 However, the sample size in this study was small and may have led to type 1 error.3" Sometimes I wonder if getting off treatment is similar to starting treatment.
Avatar n tn Librax (4X a day) Nexium (40 mgs 2X a day) Fibercon (3 pills 4X a day) Viokase 16 (4 pills 4X a day) Darvocet or Ultracet for the pain (Darvocet when I have a break through attack) Ambien (as needed) Erythromycin (1 and 1/2 Tsp - 4X a day) Since beginning the Viokase approximately four weeks ago I have found that I have some relief with the pain in my back and my overall day to day pain/discomfort has improved.
Avatar n tn , and this is something that has happened every morning since I was 12 1/2. They spontaneaously disappeared - please help, this is making me feel very lousy and though my wife understands fully, I feel very upset. I do not know if this matters, but I recently moved to a very warm climate from NY, and have been here for 13 months now. Thanks!!!!!! _______ : Dear Doug, It sounds like you need to have a formal evaluation by a urologist.
Avatar m tn Here's how to access the abstracts at Liver Meeting 2008. A list of all abstracts under the heading of "viral hepatitis" will follow. Not sure if late breaking abstracts are included. (1) Go to: http://www.aasld.org/Pages/Default.
181575 tn?1250202386 Notes from "Chronic Hepatitis B: Preventing, Detecting, and Managing Viral Resistance" by Keeffe, Emmet B., Dieterich, Douglas T., Pawlotsky, Jean-Michael, and Benhamou, Yves in Clinical Gastroenterology and Hepatology 2008;6:268-274. Full paper in http://www.sciencedirect.com/science/journal/15423565 1. Monotherapy using lamivudine has the longest history of use and shows highest rate of resistance.
Avatar f tn Hi you can do a search for fatty liver with hcv.
489867 tn?1209210894 9 hydronephrosis Hypertension 401.